Aurora (1)

Essen (1)

Los Angeles (1)

Nashville (1)

Paris (1)

Seattle (1)

Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor (1)

V600-mutated BRAF Metastatic Melanoma (1)

V600-mutated BRAF Unresectable Melanoma (1)

Terminated (1)

phase 1 (1)

Daiichi Sankyo, Inc. (1)

Plexxikon (1)

plx3397 (1)

vemurafenib (1)

drug (1)

Industry (1)

Interventional (1)

stage iii or stage iv metastatic melanoma that has not been previously treated with a selective braf inhibitor

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

May 12, 2020